{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:10:11Z","timestamp":1758957011926,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.hrtlng.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:20:54Z","timestamp":1562286054000},"page":"165-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Thyrotoxicosis-induced cardiomyopathy treated with venoarterial extracorporeal membrane oxygenation"],"prefix":"10.1016","volume":"49","author":[{"given":"Ivo","family":"Genev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle D.","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verghese","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.hrtlng.2019.06.006_bib0001","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.hrtlng.2019.06.006_bib0002","first-page":"69","article-title":"Management of thyrotoxic crisis","volume":"9","author":"Migneco","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.hrtlng.2019.06.006_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","article-title":"Cardiovascular involvement in patients with different causes of hyperthyroidism","volume":"6","author":"Biondi","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.hrtlng.2019.06.006_bib0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.hrtlng.2019.06.006_bib0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/thy.2011.0334","article-title":"Diagnostic Criteria, clinical Features, and incidence of thyroid storm based on nationwide surveys","volume":"22","author":"Akamizu","year":"2012","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.hrtlng.2019.06.006_bib0006","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","article-title":"2016 Guidelines for the management of thyroid storm from the Japan thyroid association and Japan endocrine society (First edition) the Japan thyroid association and Japan endocrine society taskforce committee for the establishment of diagnostic criteria","volume":"63","author":"Satoh","year":"2016","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.hrtlng.2019.06.006_bib0007","doi-asserted-by":"crossref","first-page":"944","DOI":"10.5114\/aoms.2013.38685","article-title":"Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology","volume":"9","author":"Ertek","year":"2013","journal-title":"Arch Med Sci"},{"issue":"19","key":"10.1016\/j.hrtlng.2019.06.006_bib0008","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2016-310391","article-title":"Pathophysiology, diagnosis and treatment of tachycardiomyopathy","volume":"103","author":"Martin","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hrtlng.2019.06.006_bib0009","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hrtlng.2019.06.006_bib0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11897-008-0026-9","article-title":"Thyrotoxic cardiac disease","volume":"5","author":"Dahl","year":"2008","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hrtlng.2019.06.006_bib0011","first-page":"259","article-title":"Myocardial arrest associated with propranolol use in thyroid storm","volume":"48","author":"Eleftheriou","year":"2010","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.hrtlng.2019.06.006_bib0012","article-title":"Propranolol-Induced circulatory collapse in a patient with thyroid crisis and underlying thyrocardiac disease: a word of caution","volume":"5","author":"Abubakar","year":"2017","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.hrtlng.2019.06.006_bib0013","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcrc.2018.01.026","article-title":"Thyrotoxicosis induced cardiomyopathy requiring support with extracorporeal membrane oxygenation","volume":"45","author":"White","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.hrtlng.2019.06.006_bib0014","unstructured":"ELSO Adult Cardiac Failure Supplement to the ELSO General Guidelines Extracorporeal Life Support Organization (ELSO) Guidelines for Adult Cardiac Failure; 2013."},{"issue":"33","key":"10.1016\/j.hrtlng.2019.06.006_bib0015","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/eurheartj\/ehv194","article-title":"Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score","volume":"36","author":"Schmidt","year":"2015","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.hrtlng.2019.06.006_bib0016","first-page":"9","article-title":"Rapid improvement of thyroid storm-related hemodynamic collapse by aggressive anti-thyroid therapy including steroid pulse","volume":"96","author":"Kiriyama","year":"2017","journal-title":"Med (United States)"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956319302778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956319302778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:35:25Z","timestamp":1758954925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956319302778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0147956319302778"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2019.06.006","relation":{},"ISSN":["0147-9563"],"issn-type":[{"type":"print","value":"0147-9563"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyrotoxicosis-induced cardiomyopathy treated with venoarterial extracorporeal membrane oxygenation","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}